DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Detection of SARS-CoV-2 virus by triplex enhanced nucleic acid detection assay (TENADA)
This article belongs to the Special Issue Chemistry and Biology of Noncanonical Nucleic Acid Structures: From Physicochemical Properties to Therapeutic Applications., SARS-CoV-2, a positive-strand RNA virus has caused devastating effects. The standard method for COVID diagnosis is based on polymerase chain reaction (PCR). The method needs expensive reagents and equipment and well-trained personnel and takes a few hours to be completed. The search for faster solutions has led to the development of immunological assays based on antibodies that recognize the viral proteins that are faster and do not require any special equipment. Here, we explore an innovative analytical approach based on the sandwich oligonucleotide hybridization which can be adapted to several biosensing devices including thermal lateral flow and electrochemical devices, as well as fluorescent microarrays. Polypurine reverse-Hoogsteen hairpins (PPRHs) oligonucleotides that form high-affinity triplexes with the polypyrimidine target sequences are used for the efficient capture of the viral genome. Then, a second labeled oligonucleotide is used to detect the formation of a trimolecular complex in a similar way to antigen tests. The reached limit of detection is around 0.01 nM (a few femtomoles) without the use of any amplification steps. The triplex enhanced nucleic acid detection assay (TENADA) can be readily adapted for the detection of any pathogen requiring only the knowledge of the pathogen genome sequence., This work was funded by Consejo Superior de Investigaciones Científicas (CSIC) (Project POC4CoV, CSIC-COV19-041), CHEST Foundation (040105-268-A1V), La Marató de TV3 Foundation (Project 202110-30-31-32-33 to R.E., C.C., V.N., V.G., J.M.), Spanish Ministry of Science and Innovation (MICINN) [PID2020-118145RB-I100 to R.E., PID2021-122271OB-I00 to V.N. and C.C.; PID2019-107158GB-I00 to R.G.] DGA and Fondos Feder (Bionanosurf E15_17R) and CIBER-Consorcio Centro de Investigación Biomédica en Red (CB06/01/0019 to R.E., CB06/01/0036 to P.M., CB16/01/00263 to J.M), Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation and European Commision, European Regional Development Fund). This research was also funded by the European Commision-NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI). We want to particularly acknowledge the patients and the Biobank of the Aragon Health System (PT20/00112), integrated in the Spanish National Biobanks Network for their collaboration., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-118145RB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2021-122271OB-I00
,
AEI PID2019-107158GB-I00
DOI: http://hdl.handle.net/10261/285781, https://api.elsevier.com/content/abstract/scopus_id/85143848121
HANDLE: http://hdl.handle.net/10261/285781, https://api.elsevier.com/content/abstract/scopus_id/85143848121